Protein Expression Market

The report "Protein Expression Market by Product (Instruments, Reagents, Kits, Consumables, Software, Services), System Type (Mammalian, Insect, Yeast), Workflow (Cloning, Translation, PTM), Scale, Protein Type, Application, Competition - Global Forecast to 2031" The global protein expression market is projected to reach USD 7.65 billion by 2031, up from USD 5.14 billion in 2026, at a CAGR of 8.3% during the forecast period. The global protein expression market is experiencing growth, driven by the expanding global biologics and biosimilar pipeline and rising government and venture capital R&D funding.

Browse 560 market data Tables and 75 Figures spread through 500 Pages and in-depth TOC on "Protein Expression Market by Product (Instruments, Reagents, Kits, Consumables, Software, Services), System Type (Mammalian, Insect, Yeast), Workflow (Cloning, Translation, PTM), Scale, Protein Type, Application, Competition - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/protein-expression-market-180323924.html

The products segment accounted for the largest share of the global protein expression market, by offering, in 2025.

Based on offering, the protein expression market is segmented into products and services. The services segment dominated the protein expression market share in 2025, driven by increasing outsourcing to CROs and CDMOs, growing complexity of recombinant protein production workflows, and the need for specialized technical expertise. Rising demand for gene synthesis, protein expression optimization, cell line development, and custom protein production services across research and manufacturing applications further supports the segment's leadership. Additionally, expansion of biologics, biosimilars, and cell and gene therapy pipelines continues to accelerate service adoption, reinforcing its dominant position in the global protein expression market.

Mammalian expression systems are estimated to be the fastest-growing type segment in the protein expression market.

The global protein expression market is segmented by type into mammalian, prokaryotic, insect, yeast, cell-free, and algal & plant-based expression systems. During the forecast period, the mammalian expression systems segment is projected to be the fastest-growing segment in the protein expression market, driven by increasing demand for monoclonal antibodies, recombinant proteins, and complex biologics. These systems provide superior protein folding and post-translational modifications essential for therapeutic applications. Additionally, the expanding biologics pipeline, increasing commercial manufacturing of biopharmaceuticals, and growing adoption of advanced cell culture technologies continue to accelerate demand for mammalian expression systems globally.

North America accounted for the largest regional share in the global protein expression market in 2025.

The protein expression market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In 2025, North America accounted for the largest share of the global protein expression market, driven by a well-established biopharmaceutical industry, strong investments in biotechnology research, and high adoption of advanced protein expression technologies. The region also benefits from significant R&D spending, expanding biologics and biosimilars development activities, and a strong presence of leading market players and research institutions. Additionally, favorable funding initiatives and growing demand for recombinant proteins and therapeutic biologics continue to support the region’s dominant market position.

Key players in the protein expression market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Agilent Technologies, Inc. (US), Sartorius AG (Germany), GenScript (US), Takara Bio Inc. (Japan), Bio-Rad Laboratories, Inc. (US), QIAGEN (Netherlands), Charles River Laboratories (US), Corning Incorporated (US), Lonza (Switzerland), FUJIFILM Corporation (Japan), Syngene International Limited (India) LGC Limited (UK), Eurofins Scientific (Luxembourg), Ajinomoto Co., Inc. (Japan).

Don’t miss out on business opportunities in Protein Expression Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]